Cargando…
The evolution of the cancer formulary review in Canada: Can centralization improve the use of economic evaluation?
Public reimbursement of drugs is a costly proposition for health care systems. Decisions to add drugs to the public formulary are often guided by review processes and committees. The evolution of the formulary review process in Canada's publicly funded health system is characterized by increase...
Autores principales: | Wranik, W. Dominika, Gambold, Liesl, Hanson, Natasha, Levy, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484361/ https://www.ncbi.nlm.nih.gov/pubmed/27469429 http://dx.doi.org/10.1002/hpm.2372 |
Ejemplares similares
-
How best to structure interdisciplinary primary care teams: the study protocol for a systematic review with narrative framework synthesis
por: Wranik, W. Dominika, et al.
Publicado: (2016) -
The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian Oncology Drug Review 2011–2017
por: Skedgel, Chris, et al.
Publicado: (2018) -
Evolution of the AMCP Format for Formulary Submissions
por: Watkins, John B., et al.
Publicado: (2020) -
Funding and remuneration of interdisciplinary primary care teams in Canada: a conceptual framework and application
por: Wranik, W. Dominika, et al.
Publicado: (2017) -
Costs of productivity loss due to occupational cancer in Canada: estimation using claims data from Workers’ Compensation Boards
por: Wranik, W. Dominika, et al.
Publicado: (2017)